Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Price to Book Ratio (P/B) on January 27, 2025: 1.95

Shanghai Labway Clinical Laboratory Co., Ltd. Price to Book Ratio (P/B) is 1.95 on January 27, 2025, a -19.46% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Shanghai Labway Clinical Laboratory Co., Ltd. 52-week high Price to Book Ratio (P/B) is 3.10 on March 21, 2024, which is 58.74% above the current Price to Book Ratio (P/B).
Shanghai Labway Clinical Laboratory Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.65 on July 24, 2024, which is -15.66% below the current Price to Book Ratio (P/B).
Shanghai Labway Clinical Laboratory Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 2.14.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years